life sciences
Coverage of life sciences in the Nexus archive.
- Opinion: What a recent op-ed got wrong about our Covid study
The article is an opinion piece rebutting a recent op-ed's inaccuracies about a Covid study. It highlights STAT's platform, First Opinion, which publishes essays and Letters to the Editor for discussion in the life sciences field.
- Opinion: U.S. dependence on China is a national security risk
The article argues that the United States' reliance on China poses a national security threat. It is an opinion piece published on STAT's First Opinion platform, which features discussions on life sciences topics.
- OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B
OpenAI researcher Miles Wang is in talks to launch a $2 billion AI drug discovery startup. The funding discussions highlight investor interest in using AI for breakthroughs in life sciences.
- Canada’s envoy to India Chris Cooter meets CM Revanth Reddy, invites CM-led delegation for Canada visit
Canada’s envoy to India Chris Cooter met with Telangana Chief Minister Revanth Reddy and invited a CM-led delegation to visit Canada. The meeting focused on Telangana’s strengths in IT, Life Sciences, Defence, and Aerospace.
- STAT+: AI company Anthropic announces it will begin developing drugs of its own
AI company Anthropic announced it will begin developing drugs, marking a new venture into life sciences. The company launched its newest application, Claude Science, and emphasized gaining hands-on experience to solve scientific problems using its AI products.
- Raising €100m for research in Europe is still very challenging, warns biotech chief [Advocacy Lab]
A Belgian life sciences leader warns that raising €100m for research in Europe remains challenging. The Biotech Act is highlighted as a potential solution to restore confidence in Europe's biotechnology competitiveness.
- What do early data from Utah’s Doctronic AI pilot show?
The article discusses early data from Utah’s Doctronic AI pilot program, which is being analyzed as part of STAT’s Health Tech newsletter exploring technology's impact on life sciences. The focus is on how AI tools like Doctronic may transform healthcare delivery and outcomes.
- OpenAI's New AI Model Rosalind Could Shave Years Off Drug Discovery. You Probably Can't Use It
OpenAI has developed GPT-Rosalind, a domain-specific AI model for drug discovery and life sciences. The model is not accessible to the general public.